Institute of Microbiology, ETH Zürich, Vladimir-Prelog-Weg 4, 8093, Zurich, Switzerland.
Med Microbiol Immunol. 2019 Aug;208(3-4):329-338. doi: 10.1007/s00430-019-00587-9. Epub 2019 Mar 9.
Memory T cell inflation is a process in which a large number of effector memory T cells accumulates in peripheral tissues. This phenomenon is observed upon certain low level persistent virus infections, but it is most commonly described upon infection with the β-herpesvirus Cytomegalovirus. Due to the induction of this large pool of functional effector CD8 T cells in peripheral tissues, the interest in using CMV-based vaccine vectors for vaccination purposes is rising. However, the exact mechanisms of memory T cell inflation are not yet fully understood. It is clear that repetitive exposure to antigen is a key determinant for memory inflation, and therefore the viral inoculum dose and the subsequent number of viral reactivation events strongly impact on the magnitude of the inflationary T cell pool. In addition, the number of CMV-specific CD8 T cells that is able to sense these reactivation events affects the size of the inflationary T cell pool. In the following, we will discuss factors that either promote or limit T cell inflation from both the virus and host perspective. These factors mostly operate by influencing the amount of available antigen or by affecting the T cell pool that is able to respond to the antigen. Furthermore, we will discuss the recent use of CMV-based vaccines in pre-clinical experimental settings, where these vectors have shown promising results by inducing prolonged effector memory T cell responses to foreign-introduced epitopes and thereby provided protection from subsequent virus or tumour challenges.
记忆 T 细胞膨胀是指大量效应记忆 T 细胞在外周组织中积累的过程。这种现象在某些低水平持续性病毒感染时观察到,但最常见于感染β疱疹病毒巨细胞病毒时。由于在外周组织中诱导了大量功能效应 CD8 T 细胞,因此使用基于 CMV 的疫苗载体进行疫苗接种的兴趣正在增加。然而,记忆 T 细胞膨胀的确切机制尚未完全阐明。很明显,重复接触抗原是记忆膨胀的关键决定因素,因此病毒接种剂量和随后的病毒再激活事件的数量强烈影响膨胀 T 细胞池的大小。此外,能够感知这些再激活事件的 CMV 特异性 CD8 T 细胞的数量也会影响膨胀 T 细胞池的大小。在下面,我们将从病毒和宿主的角度讨论促进或限制 T 细胞膨胀的因素。这些因素主要通过影响可用抗原的量或通过影响能够对抗原做出反应的 T 细胞池来发挥作用。此外,我们还将讨论 CMV 为基础的疫苗在临床前实验中的最新应用,这些载体通过诱导对外来引入表位的长期效应记忆 T 细胞反应,从而提供了对随后的病毒或肿瘤挑战的保护,显示出了有前景的结果。